Typically, cost effectiveness analyses assume a constant price between drug approvals and loss of exclusivity. It is not clear, however, to what extent that assumption is valid, particularly after taking into account drug price discounts and rebates. A paper by Lin et al. (2024) uses 2007-2023 data on drug prices from SSR Health to answer…
UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by Stephen J. Hemsley, who served as the company’s CEO from 2006 to 2017. The post How Social Media Is Reacting to UnitedHealth Group’s CEO Exit and Stock Meltdown appeared first on MedCity News.
During a panel at the Reuters Digital Health conference in Nashville, health system executives shared what they’ve learned about navigating change in tech pilots. In their view, success is determined by cultural readiness, frontline staff buy-in and a clear-eyed view of what success looks like. The post What Hospitals Have Learned About Change Management in…
KFF is tracking the Medicaid provisions in the 2025 federal budget bill, including new Medicaid work and verification requirements and a reduction in the expansion match rate for states that use their own funds to cover undocumented immigrants.
Galapagos has dropped plans for a business separation that would have enabled the legacy company to focus exclusively on developing new cancer cell therapies. Instead, Galapagos said it will pursue strategic alternatives for its assets. The post Galapagos Says ‘No’ to SpinCo and Instead Will Seek Deals for All Assets appeared first on MedCity News.
This fact sheet provides a snapshot of global malaria efforts and examines the U.S. government’s role in addressing malaria worldwide, including current programs, funding, and key issues.
This fact sheet explores the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government’s major global initiative to combat HIV/AIDS.
Women most affected by both functional and serious GI conditions, especially in midlife, are often dismissed, misdiagnosed, or forced to endure prolonged waits for specialist care. The post Dismissed, Delayed — and Done Waiting: The GI Crisis Midlife Women Can’t Afford appeared first on MedCity News.
[Sponsored] PurpleLab and Genentech executives will explore how to leverage real world data to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical development to market access — in a May 22 webinar. The post Improving the Patient Journey in Drug Development appeared first on MedCity News.
SACRAMENTO, California — El gobernador Gavin Newsom no esperaba enfrentarse a otra crisis sanitaria. En marzo, mientras el presidente Donald Trump y los republicanos del Congreso intensificaban el debate nacional sobre la posibilidad de recortar la atención médica para los estadounidenses pobres y con discapacidades, el gobernador demócrata tuvo que informar a los legisladores estatales…